Analysis of the nonperfused volume ratio of adenomyosis from MRI images based on fewshot learning
A few-shot learning framework was developed to predict the nonperfused volume ratio of adenomyosis from MRI images, achieving an area under the curve of 0.8375 for NPV ratio classification.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study developed a few-shot learning framework using convolutional neural networks to predict the nonperfused volume ratio in adenomyosis patients undergoing high-intensity focused ultrasound ablation. The researchers analyzed MRI data from 208 individuals to address the lack of qualitative interpretation standards and limited training data associated with this novel treatment approach. Results indicated that the model achieved varying levels of sensitivity and area under the curve across different prediction intervals, demonstrating its potential for selecting eligible patients and judging clinical efficacy. This paper is centrally about adenomyosis — specifically focusing on pre-treatment imaging analysis to optimize outcomes for HIFU ablation therapy.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,722 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis: A Retrospective Study 2016
- Safety and efficacy of high intensity focused ultrasound ablation therapy for adenomyosis 2009
- Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis 2018
Cited by (2)
References (61)
- Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis: A Retrospective Study via openalex
- Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis via openalex
- Safety and efficacy of high intensity focused ultrasound ablation therapy for adenomyosis via openalex
- W2154158661 via openalex
- W2165698076 via openalex
- W2441649867 via openalex
- W2601450892 via openalex
- W2604297385 via openalex
- W2604763608 via openalex
- W2766530444 via openalex
- W2791172704 via openalex
- W2808168184 via openalex
- W2808498263 via openalex
- W2884848653 via openalex
- W2889609823 via openalex
- W2900206120 via openalex
- W2904415434 via openalex
- W2908875379 via openalex
- W2913969639 via openalex
- W2919308409 via openalex
- W2919392656 via openalex
- W2924927402 via openalex
- W2935787471 via openalex
- W2944138435 via openalex
- W2945052290 via openalex
- W2951775809 via openalex
- W2952825522 via openalex
- W2955189540 via openalex
- W2958149692 via openalex
- W2963131975 via openalex
- W2963341924 via openalex
- W2963516100 via openalex
- W2963551321 via openalex
- W2963943197 via openalex
- W2964249870 via openalex
- W2965607502 via openalex
- W2972037190 via openalex
- W2977457995 via openalex
- W2979653841 via openalex
- W2979808779 via openalex
- W2981101506 via openalex
- W2981753123 via openalex
- W2981767205 via openalex
- W2982790269 via openalex
- W2984254165 via openalex
- W2991257700 via openalex
- W2991642257 via openalex
- W2992196493 via openalex
- W2995378448 via openalex
- W3000029017 via openalex
- W3003770199 via openalex
- W3099591453 via openalex
- W6717697761 via openalex
- W6735236233 via openalex
- W6735741670 via openalex
- W6736057607 via openalex
- W6749327742 via openalex
- W1997499435 via openalex
- W6752940074 via openalex
- W2054264645 via openalex
- W2117340355 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-11-07T06:14:47.903349+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:29:27.256757+00:00
- unpaywall
- last seen: 2026-11-07T06:39:01.373405+00:00